2-((2-((2-methoxy-4-(propionamidomethyl)phenyl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-N-methylbenzamide

ID: ALA4536595

Chembl Id: CHEMBL4536595

PubChem CID: 155548752

Max Phase: Preclinical

Molecular Formula: C25H27N7O3

Molecular Weight: 473.54

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CCC(=O)NCc1ccc(Nc2nc(Nc3ccccc3C(=O)NC)c3cc[nH]c3n2)c(OC)c1

Standard InChI:  InChI=1S/C25H27N7O3/c1-4-21(33)28-14-15-9-10-19(20(13-15)35-3)30-25-31-22-17(11-12-27-22)23(32-25)29-18-8-6-5-7-16(18)24(34)26-2/h5-13H,4,14H2,1-3H3,(H,26,34)(H,28,33)(H3,27,29,30,31,32)

Standard InChI Key:  SLGWUPRYZVOQMV-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4536595

    ---

Associated Targets(Human)

GRK5 Tchem G protein-coupled receptor kinase 5 (1126 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

GRK2 Beta-adrenergic receptor kinase 1 (102 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GRK5 G protein-coupled receptor kinase 5 (49 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 473.54Molecular Weight (Monoisotopic): 473.2175AlogP: 3.84#Rotatable Bonds: 9
Polar Surface Area: 133.06Molecular Species: NEUTRALHBA: 7HBD: 5
#RO5 Violations: HBA (Lipinski): 10HBD (Lipinski): 5#RO5 Violations (Lipinski):
CX Acidic pKa: 12.84CX Basic pKa: 5.74CX LogP: 4.53CX LogD: 4.53
Aromatic Rings: 4Heavy Atoms: 35QED Weighted: 0.25Np Likeness Score: -1.38

References

1. Rowlands RA, Cato MC, Waldschmidt HV, Bouley RA, Chen Q, Avramova L, Larsen SD, Tesmer JJG, White AD..  (2019)  Structure-Based Design of Selective, Covalent G Protein-Coupled Receptor Kinase 5 Inhibitors.,  10  (12): [PMID:31857838] [10.1021/acsmedchemlett.9b00365]

Source